scholarly journals Recurrent Breast Cancer in a Patient with a Ventriculoperitoneal Shunt

2015 ◽  
Vol 2015 ◽  
pp. 1-3
Author(s):  
Libby R. Copeland-Halperin ◽  
Robert A. Cohen
Keyword(s):  
Breast Cancer ◽  
Current Literature ◽  
Ventriculoperitoneal Shunt ◽  
Ductal Carcinoma ◽  
Preoperative Evaluation ◽  
Recurrent Breast Cancer ◽  
Carcinoma Of The Breast ◽  
Breast Malignancy ◽  
Infiltrating Ductal Carcinoma ◽  
Recurrent Breast

We report a case of a patient with recurrent infiltrating ductal carcinoma of the breast encasing a ventriculoperitoneal shunt. We also review the current literature regarding reports of breast malignancy around a ventriculoperitoneal shunt, as well as the potential relevance of such shunts to the preoperative evaluation and management of patients with breast cancer.

scholarly journals Metastatic Infiltrating Ductal Carcinoma of the Breast to the Colon: A Case Report and Literature Review

2013 ◽  
Vol 2013 ◽  
pp. 1-5 ◽  
Author(s):  
Salih Samo ◽  
Muhammed Sherid ◽  
Husein Husein ◽  
Samian Sulaiman ◽  
Jeffrey V. Brower ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Ductal Carcinoma ◽  
Carcinoma Of The Breast ◽  
Breast Cancer Metastases ◽  
Infiltrating Ductal Carcinoma ◽  
Ductal Breast Cancer ◽  
Cancer Metastases ◽  
History Of ◽  
Metastatic Involvement ◽  
Common Malignancy

True metastatic involvement of the colon is rare. Colonic metastases occur most commonly secondary to peritoneal metastases from intra-abdominal malignancies. Breast cancer is the most common malignancy that metastasizes hematogenously to the colon. Colonic metastatic disease mimics primary colonic tumors in its presentation. Colonic metastatic involvement is a poor prognostic sign, and the pathologist should be informed about the history of the primary breast cancer when examining the pathologic specimens. In this paper, we report a case of an ileocecal mass found to be histologically consistent with metastatic ductal breast cancer, and then we review the literature about breast cancer metastases to the gastrointestinal tract in general and colon in particular.

A Study of Lobular Carcinoma of the Breast Based on the Third National Cancer Survey in the United States of America

1979 ◽  
Vol 65 (2) ◽  
pp. 133-142 ◽  
Author(s):  
Donald Henson ◽  
Robert Tarone
Keyword(s):  
Breast Cancer ◽  
Ductal Carcinoma ◽  
Lobular Carcinoma ◽  
The United States ◽  
Incidence Rates ◽  
Carcinoma Of The Breast ◽  
The Third ◽  
Infiltrating Ductal Carcinoma ◽  
Epidemiological Surveys ◽  
Miyagi Prefecture

Cases in in situ and infiltrating lobular carcinoma of the breast reported in the Third National Cancer Survey were reviewed according to age, sex, race, and geographic distribution. The age-specific incidence rates indicate that there are two peak age periods of risk for invasive lobular carcinoma, the first occurring in ages 40-50 years and the second after age 65. The incidence rates for lobular carcinoma were compared to the incidence rates for intraductal and infiltrating ductal carcinoma reported from the Third National Cancer Survey and for total breast cancer from the Miyagi prefecture in Japan. These comparisons indicate that factors which influence the geographic variation in breast cancer play important roles in the etiology of infiltrating ductal carcinoma, but may have little effect upon the incidence of lobular carcinoma and intraductal carcinoma. The limitations of large histological epidemiological surveys are discussed.

scholarly journals Carcinoma en Cuirasse from Recurrent Breast Cancer seen on FDG-PET/CT

2015 ◽  
Vol 5 ◽  
pp. 35 ◽  
Author(s):  
Aung Zaw Win ◽  
Carina Mari Aparici
Keyword(s):  
Breast Cancer ◽  
Fdg Pet ◽  
Ductal Carcinoma ◽  
Recurrent Breast Cancer ◽  
Left Breast ◽  
Axillary Lymph Nodes ◽  
Axillary Lymph ◽  
Pet Ct ◽  
Recurrent Breast ◽  
Fdg Pet Ct

Our patient was a 36-year-old female diagnosed with Grade II ER+/PR−/Her-2 − ductal carcinoma in situ (DCIS) in the left breast. She underwent left lumpectomy and received treatment with tamoxifen and radiotherapy. Three years later, she presented with multiple diffused skin nodules on the chest and upper left arm. 18F-fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) exam showed widespread metastasis in the chest, upper left arm, left axillary lymph nodes, and left suprascapular muscle. FDG-PET/CT imaging of breast carcinoma en cuirasse is very rare. FDG-PET/CT is useful in detecting recurrent breast cancer.

scholarly journals Radiation Therapy for Locally Recurrent Breast Cancer

2012 ◽  
Vol 2012 ◽  
pp. 1-7 ◽  
Author(s):  
Joshua Siglin ◽  
Colin E. Champ ◽  
Yelena Vakhnenko ◽  
Pramila R. Anne ◽  
Nicole L. Simone
Keyword(s):  
Breast Cancer ◽  
Radiation Therapy ◽  
Local Recurrence ◽  
Current Literature ◽  
Initial Treatment ◽  
Treatment Effectiveness ◽  
Recurrent Breast Cancer ◽  
Breast Cancer Patients ◽  
Locally Recurrent ◽  
Recurrent Breast

Approximately one-third of all breast cancer patients experience local recurrence of their tumor after initial treatment. As initial treatment often employs the use of radiation therapy (RT), the standard of care for local breast cancer recurrence after initial breast conserving therapy has traditionally been surgical intervention with mastectomy. However, recent attempts to preserve the intact breast after recurrence with local excision have revealed a potential need for RT in addition to repeat breast conserving surgery as rates of local failure with resection alone remain high. Additionally, local recurrence following initial mastectomy and chest wall RT can be treated with reirradiation to increase local control. Repeating RT, however, in a previously irradiated area, is a complex treatment strategy, as the clinician must carefully balance maximizing treatment effectiveness while minimizing treatment-related toxicity. As a result, physicians have been hesitant to treat recurrent disease with repeat RT with limited data. Results from the current literature are promising and current clinical trials are underway to explore reirradiation modalities which will provide additional information on treatment-related toxicity and outcomes. This paper will review the current literature on repeat radiation therapy for locally recurrent breast cancer.

scholarly journals Diagnosis and Management of Metastatic Breast Cancer During Pregnancy by a Multidisciplinary Team: A Case Report

2019 ◽  
pp. 100-103
Author(s):  
Mahdis Mohamadianamiri ◽  
Majid Aklamli ◽  
Seyedeh Fahimeh Shojaei
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Multidisciplinary Team ◽  
Ductal Carcinoma ◽  
Metastatic Breast ◽  
Recurrent Breast Cancer ◽  
Lytic Lesion ◽  
Her Family ◽  
Outpatient Chemotherapy ◽  
Recurrent Breast

Background: When breast cancer is diagnosed during pregnancy or within the first year after delivery, the condition is named as pregnancy-associated breast cancer (PABC). Breast cancer during pregnancy is a devastating situation for the patient, her family, and the medical team. Providing guidance for diagnosis and treatment of PABC, we report a case along with review of the literature.Case presentation: Here we present a 31-year-old pregnant woman with low back pain who was referred to the gynecology ward. She was at 25 weeks and 6 days pregnancy. After workup, it was discovered that she had a lytic lesion in her spine. Further workup revealed that she had metastatic breast cancer with the pathology of invasive ductal carcinoma. After consultation with a multidisciplinary team (a gynecologist, an oncologist, a radiotherapist, a hematologist-oncologist, and a neurosurgeon), we terminated the pregnancy and put her on radiotherapy for the spine metastasis and systemic therapy. Also, we reviewed 36 pregnant patients with primary or recurrent breast cancer who were managed with outpatient chemotherapy, surgery, or surgery plus radiation therapy. Care was provided by medical oncologists, breast surgeons, and perinatal obstetricians. Conclusion: Since there are no sufficient data in the literature to guide the development of standard protocols for management of PABC patients (specially in metastatic disease), pregnant women must be followed up by a multidisciplinary team, and each case should be managed considering the gestational age and the stage of cancer.

ER, PR & HER2 Receptor status in recurrent breast cancer: Its relation to age & time of recurrence

2020 ◽  
Vol 22 (1) ◽  
pp. 16-20
Author(s):  
Abu Khaled Muhammad Iqbal ◽  
Nasima Akhter ◽  
Hasan Shahrear Ahmed ◽  
Md Rassell ◽  
AMM Yahia ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Treatment Approach ◽  
Recurrent Breast Cancer ◽  
Breast Cancer Patients ◽  
Her2 Receptor ◽  
Younger Patients ◽  
Receptor Status ◽  
Increased Risk ◽  
Neoplastic Lesions ◽  
Recurrent Breast

Background: Malignant neoplastic lesions of the breast are one of the main causes of cancer death among women. In tumor cells the expression status of Estrogen receptor (ER), progesterone receptor (PR), and c-ERBB2 (HER2/neu) are therapeutically and prognostically important markers affecting the treatment approach, management and prognosis of breast carcinoma. Objective: To explore the relation of receptor status in recurrent breast cancer to age and time of recurrence. Methods: This study was conducted in National Institute of Cancer Research and Hospital (NICRH) and included 81 female patients between 20 to 75 years with recurrent breast cancer. Detection of receptor status of ER +ve/-ve, PR +ve/-ve, Her-2+ve/-ve was based on the immunohistochemistry staining of tissue samples of malignant neoplastic lesions prepared from tissue biopsies of patients with recurrent breast cancer. All the information were recorded through the pre-structured data collection sheet and analyzed. Results: This study showed that most of the recurrent breast cancer patients were Triple negative breast cancer (TNBC) (39.5%) and among them most of them were younger patients. Younger patients with TNBC had increased risk of recurrence. Most of the recurrence occurred within 1-2 years. Conclusion: It can be concluded that the assessment of the expression of these biornarkers in recurrent tumors provides reliable information for the treatment approach of locoregional tumors. Journal of Surgical Sciences (2018) Vol. 22 (1): 16-20

Sign in / Sign up

Export Citation Format

Share Document